1) Ulke ZS, Yavru A, Camci E, et al. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy. Acta Anaesthesiol Scand 2013;57:745-8.
2) Kashiwai A, Suzuki T, Ogawa S. Sensitivity to rocuronium-induced neuromuscular block and reversibility with sugammadex in a patient with myotonic dystrophy. Case Report in Anesthesiology 2012;2012:107952.
3) Suzuki T, Kitajima O, Ueda K, et al. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients. Br J Anaesth 2011;106:823-6.
4) 山本聡美, 山本悠介, 近藤裕子ほか. 病的肥満を伴う脊髄性筋萎縮症III型妊婦におけるロクロニウムとスガマデクスの使用経験. 日臨麻会誌2015;35:311-4.
5) Yoshida F, Suzuki T, Kashiwai A, et al. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex. Acta Anaesthesiol Scand 2012;56:83-7.
6) Suzuki T, Nameki K, Shimizu H, et al. Efficacy of rocuronium and sugammadex in a patient with dermatomyositis. Br J Anaesth 2012;108:703.
7) Cammu G, Coart D, De Graeve, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients:A prospective observational study. Acta Anaesthesiol Belg 2012;63:69-73.
8) Panhuizen IF, Gold SJ, Buerkle C, et al. Efficacy, safety and pharmacokinetics of sugammadex 4mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth 2015;114:777-84.
9) Czarnetzki C, Tassonyi E, Lysakowski C, et al. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium. A randomized controlled trial. Anesthesiology 2014;121:59-67.
10) Zwiers A, van den Heuvel M, Smeets J, et al. Assessment of the potential for displacement interactions with sugammadex:A pharmacokinetic-pharmacodynamic modelling approach. Clin Drug Investig 2011;31:101-11.
11) Rezonja K, Sostaric M, Vidmar G, et al. Dexamethasone produces dose-dependent inhibition of sugammadex reversal in in vitro innervated primary human muscle cells. Anesth Analg 2014;118:755-63.
12) Gulec E, Biricik E, Turktan M, et al. The effect of intravenous dexamethasone on sugammadex reversal time in children undergoing adenotonsillectomy. Anesth Analg 2016;122:1147-52.
13) Buonanno P, Laiola A, Palumbo C, et al. Dexamethasone does not inhibit sugammadex reversal after rocuronium-induced neuromuscular block. Anesth Analg 2016;122:1826-30.